Cognitively 0 11 0 11 O
normal 12 18 12 18 O
, 18 19 18 19 O
or 20 22 20 22 O
with 23 27 23 27 O
mild 28 32 28 32 O
dementia 33 41 33 41 B-chronic_disease
, 41 42 41 42 O
as 43 45 43 45 O
assessed 46 54 46 54 O
clinically 55 65 55 65 O

Contraindications 0 17 66 83 O
to 18 20 84 86 O
PET 21 24 87 90 B-treatment
, 24 25 90 91 O
PET 26 29 92 95 B-treatment
- 29 30 95 96 I-treatment
CT 30 32 96 98 I-treatment
or 33 35 99 101 O
MR 36 38 102 104 B-treatment
( 39 40 105 106 O
e.g. 40 44 106 110 O
electronic 45 55 111 121 B-treatment
medical 56 63 122 129 I-treatment
devices 64 71 130 137 I-treatment
, 71 72 137 138 O
inability 73 82 139 148 O
to 83 85 149 151 O
lie 86 89 152 155 O
still 90 95 156 161 O
for 96 99 162 165 O
long 100 104 166 170 O
periods 105 112 171 178 O
) 112 113 178 179 O
that 114 118 180 184 O
make 119 123 185 189 O
it 124 126 190 192 O
unsafe 127 133 193 199 O
for 134 137 200 203 O
the 138 141 204 207 O
individual 142 152 208 218 O
to 153 155 219 221 O
participate 156 167 222 233 O

Has 0 3 234 237 O
any 4 7 238 241 O
condition 8 17 242 251 O
that 18 22 252 256 O
, 22 23 256 257 O
in 24 26 258 260 O
the 27 30 261 264 O
Investigator 31 43 265 277 O
's 43 45 277 279 O
opinion 46 53 280 287 O
, 53 54 287 288 O
could 55 60 289 294 O
increase 61 69 295 303 O
risk 70 74 304 308 O
to 75 77 309 311 O
the 78 81 312 315 O
participant 82 93 316 327 O
, 93 94 327 328 O
limit 95 100 329 334 O
the 101 104 335 338 O
participant 105 116 339 350 O
's 116 118 350 352 O
ability 119 126 353 360 O
to 127 129 361 363 O
tolerate 130 138 364 372 O
the 139 142 373 376 O
experimental 143 155 377 389 O
procedures 156 166 390 400 O
, 166 167 400 401 O
or 168 170 402 404 O
interfere 171 180 405 414 O
with 181 185 415 419 O
the 186 189 420 423 O
collection 190 200 424 434 O
/ 200 201 434 435 O
analysis 201 209 435 443 O
of 210 212 444 446 O
the 213 216 447 450 O
data 217 221 451 455 O
( 222 223 456 457 O
for 223 226 457 460 O
example 227 234 461 468 O
, 234 235 468 469 O
participants 236 248 470 482 O
with 249 253 483 487 O
severe 254 260 488 494 B-chronic_disease
chronic 261 268 495 502 I-chronic_disease
back 269 273 503 507 I-chronic_disease
pain 274 278 508 512 I-chronic_disease
might 279 284 513 518 O
not 285 288 519 522 O
be 289 291 523 525 O
able 292 296 526 530 O
to 297 299 531 533 O
lie 300 303 534 537 O
still 304 309 538 543 O
during 310 316 544 550 O
the 317 320 551 554 O
scanning 321 329 555 563 O
procedures 330 340 564 574 O
) 340 341 574 575 O

Has 0 3 576 579 O
hypersensitivity 4 20 580 596 O
to 21 23 597 599 O
F 24 25 600 601 B-allergy_name
18 26 28 602 604 I-allergy_name
T807 29 33 605 609 I-allergy_name
or 34 36 610 612 O
any 37 40 613 616 O
of 41 43 617 619 O
its 44 47 620 623 O
excipients 48 58 624 634 O

Male 0 4 635 639 B-gender
or 5 7 640 642 O
female 8 14 643 649 B-gender
participants 15 27 650 662 I-gender

Only 0 4 663 667 O
negative 5 13 668 676 B-pregnancy
pregnancy 14 23 677 686 I-pregnancy
test 24 28 687 691 O
result 29 35 692 698 O
would 36 41 699 704 O
allow 42 47 705 710 O
the 48 51 711 714 O
drug 52 56 715 719 O
administration 57 71 720 734 O
to 72 74 735 737 O
proceed 75 82 738 745 O

Other 0 5 746 751 O
than 6 10 752 756 O
DIAN 11 15 757 761 O
study 16 21 762 767 O
, 21 22 767 768 O
current 23 30 769 776 O
or 31 33 777 779 O
recent 34 40 780 786 O
( 41 42 787 788 O
within 42 48 788 794 O
12 49 51 795 797 B-upper_bound
months 52 58 798 804 I-upper_bound
prior 59 64 805 810 I-upper_bound
to 65 67 811 813 O
screening 68 77 814 823 O
) 77 78 823 824 O
participation 79 92 825 838 O
in 93 95 839 841 O
research 96 104 842 850 O
studies 105 112 851 858 O
involving 113 122 859 868 O
radioactive 123 134 869 880 O
agents 135 141 881 887 O
such 142 146 888 892 O
that 147 151 893 897 O
the 152 155 898 901 O
total 156 161 902 907 O
research 162 170 908 916 O
- 170 171 916 917 O
related 171 178 917 924 O
radiation 179 188 925 934 O
dose 189 193 935 939 O
to 194 196 940 942 O
the 197 200 943 946 O
participant 201 212 947 958 O
in 213 215 959 961 O
any 216 219 962 965 O
given 220 225 966 971 O
year 226 230 972 976 O
would 231 236 977 982 O
exceed 237 243 983 989 O
the 244 247 990 993 O
limits 248 254 994 1000 O
set 255 258 1001 1004 O
forth 259 264 1005 1010 O
in 265 267 1011 1013 O
the 268 271 1014 1017 O
US 272 274 1018 1020 O
Code 275 279 1021 1025 O
of 280 282 1026 1028 O
Federal 283 290 1029 1036 O
Regulations 291 302 1037 1048 O
( 303 304 1049 1050 O
CFR 304 307 1050 1053 O
) 307 308 1053 1054 O

Other 0 5 1055 1060 O
than 6 10 1061 1065 O
DIAN 11 15 1066 1070 O
study 16 21 1071 1076 O
, 21 22 1076 1077 O
currently 23 32 1078 1087 O
participating 33 46 1088 1101 O
in 47 49 1102 1104 O
any 50 53 1105 1108 O
research 54 62 1109 1117 O
study 63 68 1118 1123 O
and 69 72 1124 1127 O
receiving 73 82 1128 1137 O
an 83 85 1138 1140 O
active 86 92 1141 1147 O
study 93 98 1148 1153 O
medication 99 109 1154 1164 O
for 110 113 1165 1168 O
Alzheimer 114 123 1169 1178 B-chronic_disease
's 123 125 1178 1180 I-chronic_disease
Disearse 126 134 1181 1189 I-chronic_disease
, 134 135 1189 1190 O
an 136 138 1191 1193 O
investigational 139 154 1194 1209 O
drug 155 159 1210 1214 O
, 159 160 1214 1215 O
device 161 167 1216 1222 O
, 167 168 1222 1223 O
imaging 169 176 1224 1231 O
, 176 177 1231 1232 O
or 178 180 1233 1235 O
placebo 181 188 1236 1243 O
within 189 195 1244 1250 O
the 196 199 1251 1254 O
past 200 204 1255 1259 B-upper_bound
30 205 207 1260 1262 I-upper_bound
days 208 212 1263 1267 I-upper_bound
before 213 219 1268 1274 O
screening 220 229 1275 1284 O
, 229 230 1284 1285 O
and 231 234 1286 1289 O
throughout 235 245 1290 1300 O
this 246 250 1301 1305 O
clinical 251 259 1306 1314 O
trial 260 265 1315 1320 O
up 266 268 1321 1323 O
to 269 271 1324 1326 O
2 272 273 1327 1328 O
- 273 274 1328 1329 O
weeks 274 279 1329 1334 O
past 280 284 1335 1339 O
any 285 288 1340 1343 O
study 289 294 1344 1349 O
- 294 295 1349 1350 O
related 295 302 1350 1357 O
procedures 303 313 1358 1368 O

Pre 0 3 1369 1372 O
- 3 4 1372 1373 O
menopausal 4 14 1373 1383 O
women 15 20 1384 1389 B-gender
will 21 25 1390 1394 O
undergo 26 33 1395 1402 O
a 34 35 1403 1404 O
urine 36 41 1405 1410 O
pregnancy 42 51 1411 1420 B-pregnancy
test 52 56 1421 1425 O
within 57 63 1426 1432 O
24 64 66 1433 1435 B-upper_bound
hours 67 72 1436 1441 I-upper_bound
of 73 75 1442 1444 O
drug 76 80 1445 1449 O
administration 81 95 1450 1464 O

Severe 0 6 1465 1471 B-chronic_disease
claustrophobia 7 21 1472 1486 I-chronic_disease

Women 0 5 1487 1492 B-gender
who 6 9 1493 1496 O
are 10 13 1497 1500 O
currently 14 23 1501 1510 O
pregnant 24 32 1511 1519 B-pregnancy
or 33 35 1520 1522 O
breast 36 42 1523 1529 O
- 42 43 1529 1530 O
feeding 43 50 1530 1537 O
, 50 51 1537 1538 O
and 52 55 1539 1542 O
women 56 61 1543 1548 B-gender
who 62 65 1549 1552 O
do 66 68 1553 1555 B-contraception_consent
not 69 72 1556 1559 I-contraception_consent
agree 73 78 1560 1565 I-contraception_consent
to 79 81 1566 1568 I-contraception_consent
use 82 85 1569 1572 I-contraception_consent
reliable 86 94 1573 1581 I-contraception_consent
contraception 95 108 1582 1595 I-contraception_consent
, 108 109 1595 1596 O
or 110 112 1597 1599 O
to 113 115 1600 1602 O
refrain 116 123 1603 1610 O
from 124 128 1611 1615 O
sexcual 129 136 1616 1623 O
activity 137 145 1624 1632 O
for 146 149 1633 1636 O
24 150 152 1637 1639 O
hours 153 158 1640 1645 O
following 159 168 1646 1655 O
administration 169 183 1656 1670 O
of 184 186 1671 1673 O
the 187 190 1674 1677 O
flortaucipir 191 203 1678 1690 O
injection 204 213 1691 1700 O
will 214 218 1701 1705 O
be 219 221 1706 1708 O
excluded 222 230 1709 1717 O
from 231 235 1718 1722 O
the 236 239 1723 1726 O
study 240 245 1727 1732 O

at 0 2 1733 1735 O
least 3 8 1736 1741 O
18 9 11 1742 1744 B-lower_bound
years 12 17 1745 1750 I-lower_bound
of 18 20 1751 1753 O
age 21 24 1754 1757 B-age

